You are here: Welcome » COVID-19 » COVID-19 Treatments and Philosophies » Drug Therapies Researched or Applied to Treat COVID-19

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
covid-19:treatments:drug_therapies [2021/12/29 11:02]
mathew folding multiple articles together--needs reorg		covid-19:treatments:drug_therapies [2022/04/27 15:13] (current)
mathew
Line 27: Line 27:
   * [[COVID-19:treatments:drug_therapies:favipiravir]]   * [[COVID-19:treatments:drug_therapies:favipiravir]]
   * [[COVID-19:treatments:drug_therapies:ivermectin]]   * [[COVID-19:treatments:drug_therapies:ivermectin]]
 +  * [[COVID-19:treatments:drug_therapies:lithium]]
   * [[COVID-19:treatments:drug_therapies:molnupiravir]]   * [[COVID-19:treatments:drug_therapies:molnupiravir]]
   * [[COVID-19:treatments:drug_therapies:niclosamide]]   * [[COVID-19:treatments:drug_therapies:niclosamide]]
Line 44: Line 45:
 ===== Blood Thinners/Anticoagulants ===== ===== Blood Thinners/Anticoagulants =====
 Since clotting is among the most damaging symptoms of COVID-19, numerous [[:anticoagulants]] have been used by some doctors. Since clotting is among the most damaging symptoms of COVID-19, numerous [[:anticoagulants]] have been used by some doctors.
 +
 +===== Fusion Inhibitor Peptides =====
 +
 +==== Enfuvirtide ====
 +An in silico study showed that enfuvirtide can act as a potent [[:SARS-CoV-2]] fusion inhibitor.((September 11, 2020 | Khadijeh Ahmadi et al | Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study | [[https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1871958|https://doi.org/10.1080/07391102.2021.1871958]]))
  
 =====Immune Modulators ===== =====Immune Modulators =====
Back to top